Essential information > Timelines for data availability > Provisional timeline for future data releases
Provisional timeline for future data releases
The table below gives details of upcoming data releases and estimated dates for when each release will take place. For details
about the most recent data release and past releases see here.
Please be aware that due to the current COVID-19 pandemic UK Biobank's priorities for future data availability are under constant review and timelines are subject to change.
In addition to the releases below we plan to make regular updates to tables on the Data Portal for the Death data for England, Scotland and Wales, the Hospital Inpatient data for England & Scotland, and the Critical Care data for England. These should be made every one or two months, but this may be longer on occasion. The Covid-19 test result data for England will continue to be updated approximately every fortnight. The date that each table on the Data Portal was last updated can be found at the bottom of the timelines page.
| Type of data | About | Approximate release date |
| Telomere data | Data on telomere length for 474,000 participants. | Early March 2021 |
| NMR-metabolomics data | The first tranche of NMR-metabolomics data, from Nightingale Health, for 120,000 participants. | Early March 2021 |
| Hospital inpatient data | As well as continuing rolling updates to the English & Scottish inpatient data, we plan an update to the Welsh data to cover the period since February 2018. | Quarter 1 2021 |
| Algorithmically-defined outcome fields | The Algorithmically-defined Outcomes (Category 42) will be updated to account for the new death and inpatient data. | Quarter 1 2021 |
| Updated GP data | Further primary care (GP) data from TPP & EMIS. This data will be available to be used for COVID-19 research only. |
Quarter 1 2021 |
| Cancer data | An update to the cancer registry data. | Quarter 1/2 2021 |
| Imaging data | SARS-CoV-2 repeat imaging data | Monthly from March to August 2021 |
| SARS-CoV-2 seroprevalence data | SARS-CoV-2 seroprevalence data for 20,000 individuals | Quarter 2/3 2021 |
| SARS-CoV-2 antibody data | SARS-CoV-2 antibody lateral flow test data | Quarter 3 2021 |
| Enhanced cancer data | Cancer stage and grade. Data on cancer treatment including radiotherapy, chemotherapy cycles and surgery. | 2021 |
| Scottish and Welsh primary care data | Primary care data for Scotland and Wales will be made available on
the Data Portal. This data will be available to be used for COVID-19 research only. |
2021 |
| Additional Scottish hospital inpatient data | Scottish maternity and psychiatric data | 2021 |